TIFAB and myelodysplastic syndrome: Tifab (TRAF-interacting protein with forkhead-associated domain B) has been manifested to regulate hematopoiesis through Toll-like receptor (TLR)-TRAF6 complex and loss of Tifab induces BM failure and myelodysplastic syndrome (MDS) [36].